A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells

Molecular Brain Research

Volumn 52, Issue 1, 1997, Pages 139-145

  Lehmann, Sylvain ^a   Daude, Nathalie ^a   Harris, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Creutzfeldt Jakob disease; Genetic; Heterozygous; Metabolism; Mutant; Neurodegenerative; Prion; Scrapie

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL CULTURE; CHO CELL; CONTROLLED STUDY; GENE MUTATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SCRAPIE AGENT;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; HETEROZYGOTE; MUTATION; PRIONS; PRPSC PROTEINS;

EID: 0030827404     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00231-3     Document Type: Article

References (38)

1. Baker H.F., Poulter M., Crow T.J., Frith C.D., Lofthouse R., Ridley R.M. Amino acid polymorphism in human prion protein and age at death in inherited prion disease. Lancet. 337:1991;1286.
2. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1981;1604-1607.
3. Chen S.G., Parchi P., Brown P., Roos R.P., Vnencak-Jones C.L., Wang Q., Teller J., Gambetti P. Properties of the prion protein encoded by different alleles in familial prion diseases. Soc. Neurosci. Abstr. 21:1995;493.
4. Cohen F.E., Pan K.M., Huang Z., Baldwin M., Fletterick R.J., Prusiner S.B. Structural clues to prion replication. Science. 264:1994;530-531.
5. Collinge J., Palmer M.S., Sidle K.C.L., Gowland I., Medori R., Ironside J., Lantos P. Transmission of fatal familial insomnia to laboratory animals. Lancet. 346:1995;569-570.
6. Collinge J., Sidle K.C.L., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 383:1996;685-690.
7. Deslys J.P., Marce D., Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J. Gen. Virol. 75:1994;23-27.
8. Dlouhy S.R., Hsiao K., Farlow M.R., Foround T., Conneally P.M., Johnson P., Prusiner S.B., Hodes M.E., Ghetti B. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nature Genet. 1:1992;64-67.
9. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S.B. Mutation and polymorphism in the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Am. J. Hum. Genet. 53:1993;828-835.
10. Gabizon R., Telling G., Meiner Z., Halimi M., Kahana I., Prusiner S.B. Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nature Med. 2:1996;59-64.
11. D.C. Gajdusek, Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidoses, in: B.N. Fields, D.M. Knipe, P.M. Howley (Eds.), Virology, Lippincott-Raven, Philadelphia, 1996, pp. 2851-2900.
12. Ghetti B., Piccardo P., Spillantini M.G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B., Bugiani O., Giaccone G., Prelli F., Goedert M., Dlouhy S.R., Tagliavini F. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sci. USA. 93:1996;744-748.
13. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., Cortelli P., Julien J., Vital C., Pendelbury W.W., Haltia M., Wills P.R., Hauw J.J., McKeever P.E., Monari L., Schrank B., Swergold G.D., Autilio-Gambetti L., Gajdusek D.C., Lugaresi E., Gambetti P. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 258:1992;806-808.
14. Harris D.A., Huber M.T., van Dijken P., Shyng S.-L., Chait B.T., Wang R. Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry. 32:1993;1009-1016.
15. Kascsak R.J., Rubinstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:1987;3688-3693.
16. Kitamoto T., Lizuka R., Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 192:1993;525-531.
17. Lehmann S., Harris D.A. A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270:1995;24589-24597.
18. Lehmann S., Harris D.A. Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271:1996;1633-1637.
19. Lehmann S., Harris D.A. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. USA. 93:1996;5610-5614.
20. Nicholl D., Windl O., de Silva R., Sawcer S., Dempster M., Ironside J.W., Estibeiro J.P., Yuill G.M., Lathe R., Will R.G. Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J. Neurol. Neurosurg. Psychiatry. 58:1995;65-69.
21. Oda T., Kitamoto T., Tateishi J., Mitsuhashi T., Iwabuchi K., Haga C., Oguni E., Kato Y., Tominaga I., Yanai K., Kashima H., Kogure T., Hori K., Ogino K. Prion disease with 144 base pair insertion in a Japanese family line. Acta Neuropathol. 90:1995;80-86.
22. Palmer M.S., Dryden A.J., Hughes J.T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 352:1991;340-342.
23. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sima A.A.F., Trojanowski J.Q., Petersen R.B., Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:1996;767-778.
24. Parchi P., Gambetti P. Human prion diseases. Curr. Opin. Neurol. 8:1995;286-293.
25. Poulter M., Baker H.F., Frith C.D., Leach M., Lofthouse R., Ridley R.M., Shah T., Owen F., Collinge J., Brown J., Hardy J., Mullan M.J., Harding A.E., Bennett C., Doshi R., Crow T.J. Inherited prion disease with 144 base pair gene insertion. Brain. 115:1992;675-685.
26. Priola S.A., Caughey B., Race R.E., Chesebro B. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J. Virol. 68:1994;4873-4878.
27. Priola S.A., Chesebro B. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69:1995;7754-7758.
28. S.B. Prusiner, Prions, in: B.N. Fields, D.M. Knipe, P.M. Howley (Eds.), Virology, Lippincott-Raven, Philadelphia, 1996, pp. 2901-2950.
29. Prusiner S.B., Hsiao K.K. Human prion diseases. Ann. Neurol. 35:1994;385-395.
30. Prusiner S.B., Scott M., Foster D., Pan K.M., Groth D., Mirenda C., Torchia M., Yang S.L., Serban D., Carlson G.A., Hoppe P.C., Westaway D., DeArmond S.J. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 63:1990;673-686.
31. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Wälchli M., Torchia M., Groth D., Carlson G., DeArmond S.J., Westaway D., Prusiner S.B. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 59:1989;847-857.
32. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell. 73:1993;979-988.
33. Scott M.R., Köhler R., Foster D., Prusiner S.B. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1:1992;986-997.
34. Shyng S.L., Moulder K.L., Lesko A., Harris D.A. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270:1995;14793-14800.
35. Tagliavini F., Prelli F., Porro M., Rossi G., Giaccone G., Farlow M.R., Dlouhy S.R., Ghetti B., Bugiani O., Frangione B. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell. 79:1994;695-703.
36. Tateishi J., Brown P., Kitamoto T., Hoque Z.M., Roos R., Wollman R., Cervenákova L., Gajdusek D.C. First experimental transmission of fatal familial insomnia. Nature. 376:1995;434-435.
37. Telling G.C., Haga T., Torchia M., Tremblay P., DeArmond S.J., Prusiner S.B. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10:1996;1736-1750.
38. Telling G.C., Scott M., Mastriani J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90.